CA2719830F - CHEWING-GUM COMPOSITIONS CONTAINING CANNABINOIDS - Google Patents

CHEWING-GUM COMPOSITIONS CONTAINING CANNABINOIDS

Info

Publication number
CA2719830F
CA2719830F CA2719830A CA2719830A CA2719830F CA 2719830 F CA2719830 F CA 2719830F CA 2719830 A CA2719830 A CA 2719830A CA 2719830 A CA2719830 A CA 2719830A CA 2719830 F CA2719830 F CA 2719830F
Authority
CA
Canada
Prior art keywords
chewing
compositions containing
gum compositions
containing cannabinoids
gum composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2719830A
Other languages
French (fr)
Other versions
CA2719830A1 (en
CA2719830C (en
Inventor
Damme Philippus Anne Van
George Evgeniyevich Anastassov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STICHTING SANAMMAD
Original Assignee
STICHTING SANAMMAD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40793287&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2719830(F) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by STICHTING SANAMMAD filed Critical STICHTING SANAMMAD
Publication of CA2719830A1 publication Critical patent/CA2719830A1/en
Publication of CA2719830F publication Critical patent/CA2719830F/en
Application granted granted Critical
Publication of CA2719830C publication Critical patent/CA2719830C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
    • B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
    • B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
    • B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
    • B65D75/36—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials
    • B65D85/70—Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Composite Materials (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)

Abstract

The present invention relates to a chewing gum composition comprising 0.01 to 15 % by weight a cannabinoid or a derivative thereof, based on the total weight of the chewing gum composition, and to chewing gums and blistering packages com-prising said chewing gums.
CA2719830A 2008-03-26 2009-03-26 Chewing gum compositions comprising cannabinoids Expired - Fee Related CA2719830C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3945108P 2008-03-26 2008-03-26
US61/039,451 2008-03-26
PCT/NL2009/050149 WO2009120080A1 (en) 2008-03-26 2009-03-26 Chewing gum compositions comprising cannabinoids

Publications (3)

Publication Number Publication Date
CA2719830A1 CA2719830A1 (en) 2009-10-01
CA2719830F true CA2719830F (en) 2009-10-01
CA2719830C CA2719830C (en) 2017-08-08

Family

ID=40793287

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2719830A Expired - Fee Related CA2719830C (en) 2008-03-26 2009-03-26 Chewing gum compositions comprising cannabinoids

Country Status (15)

Country Link
US (2) US9023322B2 (en)
EP (1) EP2280687B1 (en)
BR (1) BRPI0910094B1 (en)
CA (1) CA2719830C (en)
DK (1) DK2280687T3 (en)
ES (1) ES2727648T3 (en)
HR (1) HRP20190944T1 (en)
HU (1) HUE044439T2 (en)
LT (1) LT2280687T (en)
MX (1) MX2010010607A (en)
PL (1) PL2280687T3 (en)
PT (1) PT2280687T (en)
SI (1) SI2280687T1 (en)
TR (1) TR201907776T4 (en)
WO (1) WO2009120080A1 (en)

Families Citing this family (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT2280687T (en) 2008-03-26 2019-08-26 Stichting Sanammad RUBBER RUBBER COMPOSITIONS INCLUDING CANNABINOIDS
GB2471523A (en) 2009-07-03 2011-01-05 Gw Pharma Ltd Use of tetrahydrocannibivarin (THCV) and optionally cannabidiol (CBD) in the treatment of epilepsy
TWI583374B (en) 2010-03-30 2017-05-21 Ｇｗ伐瑪有限公司 Use of plant cannabinoid cannabinol (CBDV) for the treatment of epilepsy
GB2487712B (en) 2011-01-04 2015-10-28 Otsuka Pharma Co Ltd Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy
GB2514054A (en) 2011-09-29 2014-11-12 Gw Pharma Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
US10350251B2 (en) * 2012-03-28 2019-07-16 Keith Gerald Freeman Medical compositions, methods of making and using those compositions, and kits including those compositions
US9380813B2 (en) 2014-02-11 2016-07-05 Timothy McCullough Drug delivery system and method
US10821240B2 (en) 2014-02-11 2020-11-03 Vapor Cartridge Technology Llc Methods and drug delivery devices using cannabis
US9220294B2 (en) 2014-02-11 2015-12-29 Timothy McCullough Methods and devices using cannabis vapors
US9744128B2 (en) 2014-06-05 2017-08-29 Mastix LLC Method for manufacturing medicated chewing gum without cooling
GB2530001B (en) 2014-06-17 2019-01-16 Gw Pharma Ltd Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy
GB2527599A (en) 2014-06-27 2015-12-30 Gw Pharma Ltd Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy
EP3182970A4 (en) * 2014-08-22 2018-03-21 Medipath Inc. Compositions and methods for cannabinoid coatings for use in drug delivery
GB2531278A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabidiol in the treatment of intractable epilepsy
GB2531282A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
GB2531281A (en) 2014-10-14 2016-04-20 Gw Pharma Ltd Use of cannabidiol in the treatment of intractable epilepsy
HK1247084A1 (en) 2015-02-02 2018-09-21 APIRx Pharmaceuticals, LLC Cannabinoid and sugar alcohol complex, methods to make and use
GB2539472A (en) 2015-06-17 2016-12-21 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal
GB2541191A (en) 2015-08-10 2017-02-15 Gw Pharma Ltd Use of cannabinoids in the treatment of epilepsy
EP3359142B1 (en) 2015-10-07 2020-12-09 NordicCan A/S Medical chewing gum comprising cannabinoid
GB2548873B (en) 2016-03-31 2020-12-02 Gw Res Ltd Use of Cannabidiol in the Treatment of SturgeWeber Syndrome
WO2017184584A1 (en) * 2016-04-19 2017-10-26 Ascent Pharmaceuticals, Inc. Stable packaging system for moisture and oxygen sensitive pharmaceutical dosage forms
WO2017189375A1 (en) * 2016-04-27 2017-11-02 Axim Biotechnologies, Inc. Chewing gum composition comprising cannabinoids and nicotine
US9901607B2 (en) 2016-04-28 2018-02-27 Mark J. Silen Smokeless cannabis composition and method of manufacture
US20200268652A1 (en) * 2016-05-15 2020-08-27 Betty Hess Cannabis infused bubble gum for sub-lingual delivery of cannabinoids
US10653639B2 (en) 2016-05-16 2020-05-19 Cv Sciences, Inc. Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction
US10499584B2 (en) 2016-05-27 2019-12-10 New West Genetics Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles
WO2017202424A1 (en) * 2016-05-27 2017-11-30 Medcan Pharma A/S Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin
US10765658B2 (en) * 2016-06-22 2020-09-08 Mastix LLC Oral compositions delivering therapeutically effective amounts of cannabinoids
DK3474844T3 (en) 2016-06-28 2022-08-29 Trichomeshell Ltd DOSAGE FORM FOR VAPORATION AND SMOKING
GB2551987A (en) 2016-07-01 2018-01-10 Gw Res Ltd Oral cannabinoid formulations
GB2551986A (en) 2016-07-01 2018-01-10 Gw Res Ltd Parenteral formulations
US9833408B1 (en) * 2016-07-28 2017-12-05 Allen Greenspoon Orally administrable formulation
GB2553139A (en) 2016-08-25 2018-02-28 Gw Res Ltd Use of cannabinoids in the treatment of multiple myeloma
US10278951B1 (en) 2016-09-29 2019-05-07 Jon Newland Method of treating opiate dependency using tetrahydrocannabinol extracts
EP3528804B1 (en) * 2016-10-20 2023-07-26 APIRX Pharmaceutical USA, LLC Chewing gum composition comprising cannabinoids and opioid agonists and/or antagonists
US20180147141A1 (en) 2016-11-29 2018-05-31 Axim Biotechnologies, Inc. Chewing gum composition comprising cannabinoids and gabapentin
GB2557921A (en) 2016-12-16 2018-07-04 Gw Res Ltd Use of cannabinoids in the treatment of angelman syndrome
GB2559774B (en) 2017-02-17 2021-09-29 Gw Res Ltd Oral cannabinoid formulations
GB2560019A (en) 2017-02-27 2018-08-29 Gw Res Ltd Use of cannabinoids in the treatment of leukaemia
US20190224117A1 (en) * 2017-06-14 2019-07-25 Yury Leon Shmerlis Cannabis Extract Chewing Gum
WO2018233781A1 (en) 2017-06-23 2018-12-27 Medcan Pharma A/S SACHET OF CANNABINOIDS
GB2564383B (en) 2017-06-23 2021-04-21 Gw Res Ltd Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex
US10272051B2 (en) 2017-08-28 2019-04-30 Axim Biotechnologies, Inc. Method to treat atopic dermatitis
GB2568929A (en) 2017-12-01 2019-06-05 Gw Res Ltd Use of cannabinoids in the treatment of epilepsy
GB2569961B (en) 2018-01-03 2021-12-22 Gw Res Ltd Pharmaceutical
GB201806953D0 (en) 2018-04-27 2018-06-13 Gw Res Ltd Cannabidiol Preparations
WO2020051054A1 (en) * 2018-09-04 2020-03-12 Babak Ghalili Cannabinoid and anesthetic gum and lozenge compositions and methods
US11376227B2 (en) 2018-09-04 2022-07-05 Babak Ghalili Cannabinoid and menthol gum and lozenge compositions and methods
US20200069638A1 (en) * 2018-09-04 2020-03-05 Babak Ghalili Cannabinoid and menthol gum and lozenge compositions and methods
US11154496B2 (en) 2019-01-25 2021-10-26 Nordiccan A/S Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
US11013685B2 (en) 2019-01-25 2021-05-25 Nordiccan A/S Cannabinoid chewing gum with improved release of cannabinoids
EP3914226A1 (en) 2019-01-25 2021-12-01 NordicCan A/S Cannabinoid chewing gum with improved release of cannabinoids
US11191720B2 (en) 2019-01-25 2021-12-07 Nordiccan A/S Chewing gum with improved delivery of cannabinoids
US11406593B2 (en) 2019-01-25 2022-08-09 Nordiccan A/S Cannabinoid chewing gum with high intensity sweeteners
AU2019425173B2 (en) 2019-01-25 2023-01-05 Nordiccan A/S Cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
WO2020151793A1 (en) 2019-01-25 2020-07-30 Medcan Pharma A/S Chewing gum with improved delivery of cannabinoids
US11166910B2 (en) 2019-01-25 2021-11-09 Nordiccan A/S Cannabinoid chewing gum with sugar alcohols
CN113365503A (en) * 2019-01-25 2021-09-07 诺狄更斯公司 Cannabinoid chewing gum with high intensity sweetener
ES2950141T3 (en) * 2019-01-25 2023-10-05 Nordiccan As Cannabinoid gum with sugar alcohols
US11471405B2 (en) 2019-03-01 2022-10-18 Nordiccan A/S Tableted chewing gum with enhanced delivery of cannabinoids
CN113329743B (en) 2019-03-01 2023-09-05 诺狄更斯公司 Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizer
US11253473B2 (en) 2019-03-01 2022-02-22 Nordiccan A/S Method of producing tableted cannabinoid chewing gum
US20200276118A1 (en) * 2019-03-01 2020-09-03 Medcan Pharma A/S Tableted cannabinoid chewing gum with improved release
EP3930696A1 (en) 2019-03-01 2022-01-05 NordicCan A/S Tableted chewing gum with enhanced delivery of cannabinoids
WO2020177821A1 (en) 2019-03-01 2020-09-10 Medcan Pharma A/S Tableted cannabinoid chewing gum with improved release
US10933017B2 (en) 2019-03-01 2021-03-02 Nordiccan A/S Tableted cannabinoid chewing gum with polyvinyl acetate elastomer plasticizers
US10799450B2 (en) 2019-03-01 2020-10-13 Medcan Pharma A/S Tableted cannabinoid chewing gum with layered structure
BR112021012489A2 (en) * 2019-03-01 2021-10-26 Nordiccan A/S CANABINOID CHEWING GUM IN TABLET WITH LAYER STRUCTURE
BR112021020523A2 (en) * 2019-04-17 2021-12-07 Nordiccan As Fast disintegrating cannabinoid tablets
EP4030941A1 (en) 2019-09-16 2022-07-27 Vapor Cartridge Technology LLC Drug delivery system with stackable substrates
WO2021078999A1 (en) 2019-10-25 2021-04-29 Newmark Biotech, Llc Chewing gum or lozenge composition comprising cbd
CA3158289A1 (en) 2019-11-12 2021-05-20 Mahmoud Mohamed Abdrabo MOUSTAFA Chewing gum containing synergistic medicinal compounds
GB202002754D0 (en) 2020-02-27 2020-04-15 Gw Res Ltd Methods of treating tuberous sclerosis complex with cannabidiol and everolimus
WO2021177942A1 (en) * 2020-03-03 2021-09-10 Babak Ghalili Cannabinoid and menthol gum and lozenge compositions and methods
US11160757B1 (en) 2020-10-12 2021-11-02 GW Research Limited pH dependent release coated microparticle cannabinoid formulations

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4187320A (en) * 1978-05-01 1980-02-05 Warner-Lambert Company Process for preparing chewing gum base using solid elastomer
DK161428C (en) * 1985-05-10 1991-12-16 Fertin Lab As SOLID, ORAL CARIAL EFFECTS
FR2611501B1 (en) * 1987-03-04 1991-12-06 Corbiere Jerome NOVEL PHARMACEUTICAL COMPOSITIONS FOR THE ORAL ROUTE BASED ON LYSINE ACETYLSALIELYLATE AND PROCESS FOR OBTAINING SAME
DK365389D0 (en) * 1989-07-24 1989-07-24 Fertin Lab As ANTIFUNGAL CHEMICAL GUM PREPARATION
JP2002518291A (en) * 1997-08-20 2002-06-25 フイズ テクノロジーズ リミテッド Method for improving flowability and compressibility of tablet composition
WO2001089476A1 (en) 2000-05-19 2001-11-29 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
CA2419392A1 (en) * 2000-08-14 2002-02-21 Fertin Pharma A/S Method for preparation of chewing gum with customer acceptable taste
GB2377633A (en) 2001-05-11 2003-01-22 Gw Pharmaceuticals Ltd Pharmaceutical compositions comprising the cannabinoids THC and CBD
GB2381194A (en) 2001-09-07 2003-04-30 Gw Pharmaceuticals Ltd Pharmaceutical formulations
US20020160043A1 (en) 2001-02-27 2002-10-31 Dennis Coleman Compositions and method of manufacture for oral dissolvable dosage forms
FI20020333A0 (en) * 2002-02-20 2002-02-20 Tomi Jaervinen Novel Complexes of Methylated Cyclodextrin
US7004174B2 (en) 2002-05-31 2006-02-28 Neothermia Corporation Electrosurgery with infiltration anesthesia
CA2487882A1 (en) 2002-05-31 2003-12-11 University Of Mississippi Transmucosal delivery of cannabinoids
ES2280557T3 (en) * 2002-07-02 2007-09-16 Gumlink A/S Compressed chewing gum.
US6986907B2 (en) 2003-07-28 2006-01-17 Wm. Wrigley Jr. Company Chewing gum base and chewing gum compositions
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
GB2414933B (en) 2004-06-08 2009-07-15 Gw Pharma Ltd Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
GB0416861D0 (en) * 2004-07-29 2004-09-01 Quadrant Drug Delivery Ltd Composition
PL1796485T3 (en) * 2004-08-25 2016-04-29 Intercontinental Great Brands Llc Liquid-filled chewing gum composition
GB2432312A (en) 2005-11-01 2007-05-23 Gw Pharma Ltd Pharmaceutical compositions for the treatment of pain
US20100061940A1 (en) 2006-03-16 2010-03-11 Niconovum Ab Chewing Gum Compositions Providing Rapid Release of Nicotine
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
JP2010503664A (en) 2006-09-15 2010-02-04 エコ・ファーマシューティカルズ・ビー．ブイ． Pharmaceutical dosage unit for sublingual, buccal or oral administration of water-insoluble pharmaceutically active substances
WO2008098195A2 (en) * 2007-02-09 2008-08-14 Todd Maibach Film comprising nitroglycerin
LT2280687T (en) 2008-03-26 2019-08-26 Stichting Sanammad RUBBER RUBBER COMPOSITIONS INCLUDING CANNABINOIDS

Also Published As

Publication number Publication date
CA2719830A1 (en) 2009-10-01
MX2010010607A (en) 2011-03-29
HRP20190944T1 (en) 2019-09-20
US20110097283A1 (en) 2011-04-28
BRPI0910094B1 (en) 2021-08-10
US9023322B2 (en) 2015-05-05
WO2009120080A1 (en) 2009-10-01
BRPI0910094A2 (en) 2015-12-15
EP2280687A1 (en) 2011-02-09
LT2280687T (en) 2019-08-26
HUE044439T2 (en) 2019-10-28
PT2280687T (en) 2019-06-04
SI2280687T1 (en) 2019-09-30
TR201907776T4 (en) 2019-06-21
EP2280687B1 (en) 2019-02-27
DK2280687T3 (en) 2019-05-27
PL2280687T3 (en) 2019-10-31
CA2719830C (en) 2017-08-08
ES2727648T3 (en) 2019-10-17
US9433601B2 (en) 2016-09-06
US20150209322A1 (en) 2015-07-30

Similar Documents

Publication Publication Date Title
CA2719830F (en) CHEWING-GUM COMPOSITIONS CONTAINING CANNABINOIDS
BR112012011583A2 (en) buccal compositions for dry mouth treatment
CY1119945T1 (en) PHARMACEUTICAL COMPOSITION OF N- [2,4-Bis (1,1-Dimethylethyl) -5-hydroxyphenyl] -1,4-dihydro-4-oxoquinoline-3-carboxamide and spore
BRPI0911847B8 (en) nicotine gum compositions
CR20150097A (en) IMMUNOGENIC COMPOSITION
BR112013026802A2 (en) improved peroxide stability in oral treatment compositions
BRPI0500704A (en) rehydratable personal care compositions
MX342107B (en) Coating compositions, confectionery and chewing gum compositions and methods.
BRPI0408895A (en) Cladribine formulations for improved oral and transmucosal administration
TNSN07360A1 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
WO2008013840A3 (en) Erastin analogs and uses thereof
EA200602104A1 (en) PHARMACEUTICAL COMPOSITION DISPENSABLE IN THE FATAL CAVITY, FOR HUMOR-BODY OR SUBLINGUAL ADMINISTRATION AGOMELATIN
MX2009013021A (en) Center-fill gum compositions incorporating triacetin.
BR112012032882A2 (en) increased release of lopophilic ingredients from hydrocolloid chewing gum
WO2007012080A3 (en) Oral care composition
WO2007117629A3 (en) Impact of calcium phosphate complex on dental caries
ATE442153T1 (en) COMPOSITIONS FOR IMPROVING GUT HEALTH AND ANIMAL PERFORMANCE CONTAINING BETA-GLUCANS AND ALFA-FUCANS
BR112012010455A2 (en) buccal compositions for dry mouth treatment
MX2011009364A (en) Chewing gum compositions providing flavor release profiles.
DK1971216T4 (en) CHEWING GUM CONTAINING STYRENE-DIEN BLOCK COPYLYMERS
BRPI0519414A2 (en) oral composition, paste or gel composition, and methods for inhibiting bacterial growth in the oral cavity, and for maintaining systemic health
GEP20135733B (en) Novel diazeniumdiolate derivatives, their preparation method and pharmaceutical compositions containing them
MX2009003459A (en) 2, 3, 3 -trimethylcyclopent-3 -enecarbaldehyde derivatives useful as odorants.
WO2010121213A3 (en) Antibacterial compositions
BR112013003698A2 (en) oral moistening gum compositions and products containing the same

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140228

MKLA Lapsed

Effective date: 20210326